BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32722851)

  • 1. Carnosol suppresses RANKL-induced osteoclastogenesis and attenuates titanium particles-induced osteolysis.
    Li Y; Lin S; Liu P; Huang J; Qiu J; Wen Z; Yuan J; Qiu H; Liu Y; Liu Q; Zhou T; Luo P; Guo H; Ma Y; Guo D; Mo G; Tang Y; Xu L; Liang D; Xu J; Ding Y; Zhang S
    J Cell Physiol; 2021 Mar; 236(3):1950-1966. PubMed ID: 32722851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccarin prevents titanium particle-induced osteolysis and inhibits RANKL-induced osteoclastogenesis by blocking NF-κB and MAPK signaling pathways.
    Liu Y; Song FM; Ma ST; Moro A; Feng WY; Liao SJ; Lin XX; Zhao JM; Wang ZY; Xu J; Zhan XL; Liu Q
    J Cell Physiol; 2019 Aug; 234(8):13832-13842. PubMed ID: 30637734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theaflavin-3,3'-digallate represses osteoclastogenesis and prevents wear debris-induced osteolysis via suppression of ERK pathway.
    Hu X; Ping Z; Gan M; Tao Y; Wang L; Shi J; Wu X; Zhang W; Yang H; Xu Y; Wang Z; Geng D
    Acta Biomater; 2017 Jan; 48():479-488. PubMed ID: 27838465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Luteoloside prevents lipopolysaccharide-induced osteolysis and suppresses RANKL-induced osteoclastogenesis through attenuating RANKL signaling cascades.
    Song F; Wei C; Zhou L; Qin A; Yang M; Tickner J; Huang Y; Zhao J; Xu J
    J Cell Physiol; 2018 Feb; 233(2):1723-1735. PubMed ID: 28681916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inhibition of RANKL-induced osteoclastogenesis through the suppression of p38 signaling pathway by naringenin and attenuation of titanium-particle-induced osteolysis.
    Wang W; Wu C; Tian B; Liu X; Zhai Z; Qu X; Jiang C; Ouyang Z; Mao Y; Tang T; Qin A; Zhu Z
    Int J Mol Sci; 2014 Nov; 15(12):21913-34. PubMed ID: 25464380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dehydrocostus lactone attenuates osteoclastogenesis and osteoclast-induced bone loss by modulating NF-κB signalling pathway.
    Hu B; Wu F; Shi Z; He B; Zhao X; Wu H; Yan S
    J Cell Mol Med; 2019 Aug; 23(8):5762-5770. PubMed ID: 31225720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bulleyaconitine A prevents Ti particle-induced osteolysis via suppressing NF-κB signal pathway during osteoclastogenesis and osteoblastogenesis.
    Zhang L; Feng M; Li Z; Zhu M; Fan Y; Chu B; Yuan C; Chen L; Lv H; Hong Z; Hong D
    J Cell Physiol; 2018 Sep; 233(9):7067-7079. PubMed ID: 29388671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arctigenin inhibits RANKL-induced osteoclastogenesis and hydroxyapatite resorption in vitro and prevents titanium particle-induced bone loss in vivo.
    Wei G; Liang T; Wei C; Nong X; Lu Q; Zhao J
    J Cell Biochem; 2019 Apr; 120(4):5367-5376. PubMed ID: 30317692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Puerarin inhibits titanium particle-induced osteolysis and RANKL-induced osteoclastogenesis via suppression of the NF-κB signaling pathway.
    Tang W; Xiao L; Ge G; Zhong M; Zhu J; Qin J; Feng C; Zhang W; Bai J; Zhu X; Wei M; Geng D; Wang Z
    J Cell Mol Med; 2020 Oct; 24(20):11972-11983. PubMed ID: 32896108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carnosol attenuates RANKL-induced osteoclastogenesis in vitro and LPS-induced bone loss.
    Chen Y; Lu J; Li S; Zhang C; Yang Q; Hu B; Zhou C; Hong J; Jiang G; Yan S
    Int Immunopharmacol; 2020 Dec; 89(Pt A):106978. PubMed ID: 33039968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of ursolic acid on osteoclastogenesis and titanium particle-induced osteolysis are mediated primarily via suppression of NF-κB signaling.
    Jiang C; Xiao F; Gu X; Zhai Z; Liu X; Wang W; Tang T; Wang Y; Zhu Z; Dai K; Qin A; Wang J
    Biochimie; 2015 Apr; 111():107-18. PubMed ID: 25681755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of metallic magnesium degradation products on osteoclast-induced osteolysis and attenuation of NF-κB and NFATc1 signaling.
    Zhai Z; Qu X; Li H; Yang K; Wan P; Tan L; Ouyang Z; Liu X; Tian B; Xiao F; Wang W; Jiang C; Tang T; Fan Q; Qin A; Dai K
    Biomaterials; 2014 Aug; 35(24):6299-310. PubMed ID: 24816285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyanidin Chloride inhibits ovariectomy-induced osteoporosis by suppressing RANKL-mediated osteoclastogenesis and associated signaling pathways.
    Cheng J; Zhou L; Liu Q; Tickner J; Tan Z; Li X; Liu M; Lin X; Wang T; Pavlos NJ; Zhao J; Xu J
    J Cell Physiol; 2018 Mar; 233(3):2502-2512. PubMed ID: 28771720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of osteoclastogenesis by histone deacetylase inhibitor Quisinostat protects mice against titanium particle-induced bone loss.
    Zhang L; Zhang L; You H; Sun S; Liao Z; Zhao G; Chen J
    Eur J Pharmacol; 2021 Aug; 904():174176. PubMed ID: 34004213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhoifolin ameliorates titanium particle-stimulated osteolysis and attenuates osteoclastogenesis via RANKL-induced NF-κB and MAPK pathways.
    Liao S; Song F; Feng W; Ding X; Yao J; Song H; Liu Y; Ma S; Wang Z; Lin X; Xu J; Zhao J; Liu Q
    J Cell Physiol; 2019 Aug; 234(10):17600-17611. PubMed ID: 30854667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
    Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
    J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scutellarin inhibits RANKL-mediated osteoclastogenesis and titanium particle-induced osteolysis via suppression of NF-κB and MAPK signaling pathway.
    Zhao S; Sun Y; Li X; Wang J; Yan L; Zhang Z; Wang D; Dai J; He J; Wang S
    Int Immunopharmacol; 2016 Nov; 40():458-465. PubMed ID: 27728897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stachydrine prevents LPS-induced bone loss by inhibiting osteoclastogenesis via NF-κB and Akt signalling.
    Meng J; Zhou C; Zhang W; Wang W; He B; Hu B; Jiang G; Wang Y; Hong J; Li S; He J; Yan S; Yan W
    J Cell Mol Med; 2019 Oct; 23(10):6730-6743. PubMed ID: 31328430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects of melatonin on titanium particle-induced inflammatory bone resorption and osteoclastogenesis via suppression of NF-κB signaling.
    Ping Z; Wang Z; Shi J; Wang L; Guo X; Zhou W; Hu X; Wu X; Liu Y; Zhang W; Yang H; Xu Y; Gu Y; Geng D
    Acta Biomater; 2017 Oct; 62():362-371. PubMed ID: 28867647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.